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The propagation of antibiotic resistance increases the chances of major infections for patients during hospitalization and the spread
of health related diseases. Therefore finding new and effective solutions to prevent the proliferation of pathogenic microorganisms
is critical, in order to protect hospital environment, such as the surfaces of biomedical devices. Modern nanotechnology has proven
to be an effective countermeasure to tackle the threat of infections. On this note, recent scientific breakthroughs have demonstrated
that antimicrobial nanomaterials are effective in preventing pathogens from developing resistance. Despite the ability to destroy a
great deal of bacteria and control the outbreak of infections, nanomaterials present many other advantages. Moreover, it is unlikely
for nanomaterials to develop resistance due to theirmultiple and simultaneous bactericidalmechanisms. In recent years, science has
explored more complex antimicrobial coatings and nanomaterials based on graphene have shown great potential in antibacterial
treatment. The purpose of this article is to deepen the discussion on the threat of infections related to surface disinfection and to
assess the state of the art and potential solutions, with specific focus on disinfection procedures using nanomaterials.
1. Introduction
One of the most important routine practices in dental units
is the chemical disinfection of surfaces and instruments for
infection control. When it comes to selecting disinfectants, it
is crucial to take into account several aspects, such as timing,
disinfection methods, the risks posed by using germicides,
and factors affecting their effectiveness [1]. Chemical disin-
fectants are essentially active substances in aqueous solutions,
engaged in different forms according to their final purpose:
immersion, sterilization, disinfection, and decontamination
of medical equipment, such as sprays to disinfect the sur-
faces. Sterilizing and disinfectant products are classified in
three levels: high, intermediate, and low, according to the
pathogens they are able to kill [2–5]. However, it should
be remembered that sterilization with sterilizing by means
of chemical products, for critical and semicritical items, is
always the second choice in terms of process to be imple-
mented on thermosensitive material (for which sterilizing
with heat is not advised). The correct use of disinfectants
should take into account the fact that the biocide property
is influenced by the concentration, time of contact, and
potential traces of interfering material or substances (e.g.,
organic fluids, soap, metallic ions, and pH) [6–8]. Ideally, the
perfect disinfectant should possess a complete antimicrobial
spectrum, act rapidly and persistently, lack toxicity to humans
and the environment, be compatible with the material to
treat, be chemically stable, and be economical and easy to use.
Actually, no product meets all these requirements; therefore,
we need to find the best possible compromise to achieve
the ideal result, minimizing the disadvantages related to
their use [9]. In order to reach this target, all the details
and information written in the technical sheet and safety
documents provided by the manufacturer must be carefully
analysed. All the chemical and physical features are listed
in this documentation, and there are instructions for the
correct usage and disposal in order to prevent the equipment
from being damaged and protect the worker’s safety at the
same time. Once a disinfectant passes the cell wall, it is
able to act on the pathogen organism through coagulation
mechanisms and protein oxidation of microbial cells and
by denaturalizing bacterial enzymes. If these substances are
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compatible, they can be used in association and produce a
synergetic action that enhances the technical features of the
final product [10]. There are several compounds that can be
divided into groups according to the basic compound they
originate from.There is a wide range of disinfectants available
on the market, including halogen compounds like sodium
hypochlorite, alcohols, peroxygen compounds like hydrogen
peroxide, and aldehydes like glutaraldehyde, all of which have
a broad efficacy spectrum if used appropriately. Other types
of disinfectants such as phenols, quaternary ammonium
compounds, and biguanides (including chlorhexidine) are
mostly ineffective with nonenveloped viruses and bacterial
spores, andmost of them have limited ability to kill mycobac-
teria [11, 12]. Chemical products like disinfectant, germicide,
microbiocide, and biocide are often confused, and many
of their synonyms imply a broad spectrum of efficiency
against multiple microbial pathogens. Nevertheless, a certain
product may potentially be effective only against one class of
microorganism.Themain target of the disinfection process is
to interrupt the transmission of pathogens from an infected
subject to a susceptible host. Chemical disinfection is gen-
erally limited to the use of liquid germicides on equipment
and environmental surfaces. Surface contamination of a
pathogen shed into the environment can occur directly or
by means of settled aerosols. Environmental factors such
as temperature, relative humidity, the specific nature of
the pathogen, and its suspending medium determine the
survival of these organisms. Their lifespan ranges from a
few minutes to weeks and even months. During this period
of time, contact with the contaminated item can lead to
direct inoculation of a susceptible host or, more commonly,
contamination of another vehicle, like the hands, through
which indirect inoculation occurs. Disinfectants may prove
effective in preventing the survival of pathogens and their
transfer to subordinate vehicles and ultimately to susceptible
hosts [13]. Nevertheless, chemical disinfection should only
be employed when heat sterilization is not possible. In
some cases however, it is necessary to perform a high-level
chemical disinfection of the medical instruments after each
use [14]. Evaluating the patients’ and staff ’s risk exposure to
potentially contaminated surfaces (directly or from settled
aerosols), such as frequently contacted surfaces, is crucial to
determining the need to disinfect environmental surfaces.
There are three basic principles, of equal importance, that
must be followed to achieve a successful result. It is important
to choose a good product since poor disinfectants will fail
even if properly applied. Applying the correct protocol for
the selected product is also very important because even
using a good product may prove ineffective if the method
of application is not good contact with the contaminated
surface/s. Disinfection presents a duality within its nature. A
disinfectant is a powerful substance engineered to kill and
can pose a serious threat if used frequently or improperly
[15]. Resistance to germicides is extremely rare and, yet,
lately there has been significant interest in the fact that there
are some mechanisms of bacterial resistance that overlap
between germicides and antibiotics, which in either way are
bacterial toxins. Thus, the exposure to sublethal concentra-
tions of germicides may trigger antibiotic resistance.
2. Antibiotic Resistance
At the beginning of the twentieth century, infectious diseases
were the main cause of death in the world and only with
the introduction of antibiotics was it possible to reduce
the mortality rate caused by them. These molecules revo-
lutionized modern medicine, saving millions of lives and
containing many serious infections. They were considered as
“wonder drugs” because of their nature: these are chemical
compounds produced by actinomycetes, fungi, or bacteria
capable of acting on other microorganisms inhibiting growth
(bacteriostatic effect) or killing them (bactericidal effect).
Antibiotics have many modes of action, such as inhibiting
the synthesis of a bacterial cell wall, biosynthesis of proteins,
RNA, DNA, and disrupting membrane organization. The
use of antibiotics began with the commercial production of
penicillin at the end of 1940 and was a great success until the
development of newer more effective molecules in the 1980s
[16]. In the last decade, these medicines remained one of the
most commonly prescribed classes of drugs, with 70 billion of
doses consumed [17]. An unforeseen aspect, after discovery
of antibiotics, was their widespread use, abuse, and misuse in
various forms and in different parts of the world. The level of
antibiotic-resistant infections was found to be strongly linked
to the increase of antibiotic consumption [18]. Over the next
five decades since the introduction of these drugs, there
has been an unprecedented natural selection in evolutionary
history that had led to an increasing number of resistant
strains [19].The discovery of newmolecules and the chemical
modification of existing ones, however, did not overcome the
problem. In addition, the development of antimicrobial drugs
gave a low return on investment, so since the late 1980s, it was
possible to observe a gap in the production of antimicrobials,
which was abandoned in favour of medicines that allowed for
a greater profit. This had further contributed to the current
crisis in the fight against drug-resistant pathogens [20].
Antibiotic-resistant organisms are known as “superbugs,”
which are no longer sensitive to antibiotic and continue to
multiply in its presence. The World Health Organization
estimated 25,000 deaths due to drug-resistant infections
every year only in Europe, while in the United States, more
than 63,000 patients die every year from hospital-acquired
bacterial infections that cost about $35 billion to society,
causing discomforts also economically [16]. The first serious
clinical threat in fighting infectious diseases occurred with
Enterococcus Vancomycin-resistant strains (VRE), which
possess intrinsic resistance to many of the commonly used
antibiotics and, perhaps more importantly, the ability to gain
resistance to many antibiotics present on the market [21].
Among other things, recent American studies have found
thatmore than 40% of Staphylococcus aureus strains collected
in hospitals resulted in being resistant to methicillin (strains
of S. aureus methicillin-resistant, MRSA) and some of them
also to vancomycin (multidrug-resistance), unfortunately a
recentmolecule [22]. Antibiotic resistance is a natural process
that occurs via gene level mutation and for this reason it is
impossible to overcome or prevent its development. Indeed,
a simple selective pressure and an imperfect chromosome
replication lead to acquiring one or more mutations in the
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protein or gene target of the antibiotic that prevents binding
(transforming the target into insensitive variants) [23]. The
new antibiotic capability by bacteria is acquired de novo by
geneticmutations or obtained from an external source. In fact
bacteria are able to transfer and interchange genetic material
directly between each other by transferring plasmids. This
mechanism is known as horizontal gene transfer (HGT) and
it is common among bacteria, even among those that are phy-
logenetically distant [24]. It is considered as one of the most
important reasons in the evolution of drug resistance that
acts in association with natural selection. Resistant bacteria
can also spread in the environment thanks to the presence of
human and animal excrements, as in the case of farms and
wastewaters, which are able to convey such microorganisms,
spreading them elsewhere. Antibiotic-resistant species and
traces of drugs can pass through the intestines of humans
and animals, contaminating subsequently waters and soils:
in fact, rivers and lands cultivated with the use of organic
fertilizers coming from animals fed with antibiotics would
be able to induce the proliferation of bacteria resistant to
them [25]. Bacteria that are not annihilated by antibiotics
resist their action and continue to multiply, creating increas-
ingly resistant strains which, after being fortified, may reach
our organism by passing through the aquifers or the food
grown on contaminated soils. Nowadays water resources
are among the major sources of hyperresistant bacteria [26,
27]. Resistant bacteria are involved in the high incidence of
healthcare-acquired infections (HAIs), recognized as critical
emergence in hospitals and clinics around the world. Infected
patients disseminate and release many multidrug-resistant
Gram-negative and Gram-positive species to other ones and
to healthy people: such bacteria share the ability to survive
on various hospital surfaces for long periods and for this
reason they are difficult to eradicate by cleaning and chemical
disinfection. From surfaces, pathogens may infect patients by
direct contact or indirectly, bymeans of the hands ofmedicals
and healthcare workers. Thus cleaning and surface disinfec-
tion are very important in order to limit their transfer and
reduce their diffusion [28]. The efficacy of cleaning practices
can be affected by many factors, which can compromise the
disinfectant action itself. Many studies report that different
types of surfaces prepossess the bacteria removal properties
[29]. Besides, an inadequate use of disinfectants and incorrect
contact times result in low surface disinfection. If manu-
facturer’s instructions are not followed, contaminations of
sanitiser solutions may also occur worsening the situation
[30]. In addition, the use of disinfectant wipes with a poor
germicide activity and composed of a considerable quantity
of cellulose or cotton (which can sequestrate quaternary
ammonium molecules) may decrease their efficaciousness
and serve conversely as means for microbes [31, 32]. New
disinfectants, antimicrobial surfaces, automated dispersal
systems, UV irradiation, hydrogen peroxide decontamina-
tion, and steam treatments could represent novel overtures
in contrast with the traditional and often ineffective cleaning
methods; however, they are more expensive than usual ones
[33].
So with the aim of preventing and controlling infectious
diseases caused by multidrug-resistant bacteria, we need
continually to develop new strategies and therapeutic inno-
vations to contribute to the fight against antibiotic resistance.
For this reason, during the last years, a great importance was
given to the research of novel substances and compounds
with antimicrobial activity. In this regard, nanomaterials and
nanoscience seem to be a good solution in solving this public
health problem.
3. Graphene-Based Nanomaterials as
Novel Antimicrobial Drugs
A new perspective in the treatment of bacterial infections
is offered by the use of nanomaterials and nanoparticles
as novel and nontraditional antibacterial agents [34–37]. In
particular, more recently, graphene has been proposed as
a novel antimicrobial material. Graphene is a single-layer
sheet of carbon atoms that are packed closely in a two-
dimensional (2D) honeycomb lattice. It has unique physico-
chemical properties including a high surface area, extraordi-
nary electrical and thermal conductivity, and strongmechan-
ical strength [38–40]. Graphene and its derivatives (like
graphene nanoplatelets, multilayer graphene flakes, graphene
oxide, and reduced graphene oxide) are considered graphene-
based nanomaterials (GFNs) and have been studied exten-
sively in material science, chemistry, biotechnology, and
nanomedicine for a wide range of applications including
biosensing/bioimaging, disease diagnostics, drug delivery,
and photothermal therapy [41–46]. GFNs vary in shape,
size, surface area, layer number, lateral dimensions, surface
chemistry, stiffness, defect density or quality of the indi-
vidual graphene sheets, and purity; and all these properties
significantly influence the interaction of GFNs with biolog-
ical systems [47]. Generally, GFNs with small size, sharp
edges, and rough surfaces easily internalize into the cell as
compared to larger, smooth GFNs [48]. GFNs, particularly
monolayer graphene, have the theoretical maximum surface
area because every atom lies on the surface, providing an
extremely high capacity for drug delivery [49, 50]. In partic-
ular, more recently, graphene has been proposed as a novel
antimicrobial material, with a strong cytotoxic effect on both
Gram-positive and Gram-negative bacteria and fungi [48–
52] but a very low cytotoxic effect on human cells and animal
models [53, 54]. In general, with respect to carbon nanotubes,
graphene-based nanomaterials are preferable due to the lower
production cost and ease of manipulation. With reference
to antimicrobial application, graphene-based materials are
preferred with respect to carbon nanotube due to their better
efficiency against bacteria and ease of use [51]. Reports
indicate that GFNs exert cytotoxicity in both in vitro and in
vivo studies in various types of bacteria, mammalian cells,
and animal models [53]. Among them, graphene oxide (GO)
has good antibacterial effect against Pseudomonas aerugi-
nosa and Staphylococcus aureus compared to benzalkonium
chloride one, a common surface disinfectant. Reduced GO
(rGO) can be also used as an antibacterial surface when
it is activated by solar near-infrared irradiation that gives
it the ability to kill the majority of airborne bacteria on
contact, proving to be a very efficient coating nanomaterial
[55]. It has been shown that these nanostructures also have
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a remarkable antimicrobial activity against some multidrug-
resistant bacteria such as Klebsiella pneumoniae, Escherichia
coli, and P. aeruginosa [56]. Most published studies have
evaluated graphene oxide (GO) and reduced GO (rGO) due
to their better solubility/dispersibility/stability in water and
under physiological conditions compared to other GFNs.
However, it is demonstrated that GO and rGO induce
formation of reactive oxygen species (ROS), which are rep-
resentative of an induced oxidative stress on the cell. On
the contrary, it is demonstrated that multilayer graphene
flakes and graphene nanoplatelets have cytotoxic effect on
bacteria cell but without induction of ROS [53]. Like in
other types of nanocompound, the antimicrobial effect of
graphene derivatives is defined by mechanical interactions
damaging cell walls and by its chemical oxidation that lead to
the generation of reactive oxygen species (ROS) [57]. Several
works report the development and production of graphene-
based nanomaterials, zinc-oxide nanostructures, and zinc-
oxide-decorated graphene nanoplatelets [58, 59] for use as
severe antibacterial and antibiofilm agents [60–62] (Figure 1)
but without exerting relevant cytotoxic effect on human
cells in vitro. Physical interaction between nanomaterial and
bacterial cell leads to a direct damage of the cell wall, whereas
chemical interaction leads primarily to formation of reactive
oxygen species (ROS), which are representative of an induced
oxidative stress on the cell. In particular, this developed
nanomaterial does not induce ROS production on the cell,
and for this reason it can produce a cytotoxic effect on
bacteria and fungi but not on human cells and animal models
[60]. In general, the antibacterial action of nanomaterials and
nanoparticles involves both physical and chemical effects.
The interaction mechanisms that can be considered as the
main cause of the antimicrobial effects of nanoparticles and
graphene-based materials cannot be understood or expected
without taking into consideration the fact that phenomena
intrinsic to the nanoscale are governed by quantum effects
and by the domain of the phenomena of surface and inter-
face. It is known that nanostructures and nanoparticles are
characterized by an increasing ratio between surface and
volume atoms, as their size decreases. Therefore, nanoparti-
cles are characterized by a much stronger surface interaction
capability with other objects than microsized particles. In
graphene, volume approaches zero and surface area infinity;
it is thus understood that nanostructures have a much higher
probability to get in touch and interact strongly with bacterial
cell than microparticles [63]. There are several interaction
mechanisms between nanomaterials and cell walls. Among
them is bacterial wrapping: this mechanism characterizes
the interaction, for example, of graphene nanoplatelets with
bacteria, as shown in Figure 2. The D-nanostructure adheres
to the bacterium surface and induces mechanical stress [64–
66]. Several results report on the important role of 2D basal
planes rather than edges in antimicrobial properties, in which
completely flat Langmuir–Blodgett films act against bacterial
cells having few contacts with sheet edges [67, 68]. This
antimicrobial mechanism is a valuable alternative to biocide-
releasing surfaces that uses antibiotics or silver, which are
depleted from the surface over time [69]. Antimicrobial GFN
surfaces also avoid the release of toxic biocides, relevant
in the design of antimicrobial surfaces for environmental
applications [70].
Another antimicrobialmechanism is based onmembrane
punctuation: nanostructures adhere to the cell wall and pene-
trate through the membrane with their sharp edges as shown
in Figure 3. This mechanism is a characteristic of both D and
1D nanostructures (like GNPs and ZnO-NRs) [71] and it is
particularly effective in case of GNPs decorated with ZnO-
NRs (ZNGs), because the 2D shape of the supporting GNP
enables the 1D ZnO-NRs decorating its surface to penetrate
the cell wall [72]. Strategy to decorate GO nanosheets with
structure-featured metal oxides was also addressed [73]. In
fact, these nanomaterials took advantage of the large specific
surface area and morphological features from graphene,
but also introduced the bacterial activities of metal oxides
simultaneously. Recently, the synthesis of Zn–CuO@GO
nanosheets to apply as disinfectants has been carried out and
demonstrated their activities to combat against multi-drug-
resistant bacteria strains, such as a E. colimultidrug-resistant
strain and a methicillin-resistant S. aureus strain [74]. The
nanosheets, inhibiting bacterial growth via physical damage,
function as effective antibacterial agents. In this way, possible
genetic mutation and development of other drug-resistant
mechanisms might not be applicable.
Graphene is also able to induce antiadhesion of the
bacterial cells over the substrate for biofilm formation and it
is particularly effective in order to prevent biofilm formation,
as shown in Figure 4 [61].
The mechanism based on ROS generation does not seem
to be activated by the nanostructures shown in Figure 1,
because graphene is fully reduced andZnO is a biocompatible
material. This limits the cytotoxicity induced on human cells
in vitro or on animal models like Caenorhabditis elegans [60]
as it was observed in the case of GO [75–77].
Moreover, the development of bacterial resistance to
such nanomaterials is improbable because of their multiple
and simultaneous bactericidal mechanisms [78, 79]. Various
medical devices such as synthetic fibers, venous catheters,
and surgical instruments have already been treated with
nanoantimicrobial coatings, using silver nanoparticles in
order to fight nosocomial infections and subsequent bacterial
resistance [80].
4. Conclusions
Health associated diseases are the main unwanted con-
sequence of the spread of antibiotic resistance, so that,
during hospitalization, the risk of serious infections for a
patient is increasing. This suggests finding innovative and
functional remedies to curb the propagation of pathogenic
microorganisms from the surface of biomedical devices to the
surrounding hospital environment.With this purpose, nowa-
days nanotechnology proves to be an excellent weapon in
the struggle against infection. One of the recent efforts is the
discovery of antimicrobial nanomaterials, so that pathogens
may not be able to develop resistance. They have several
advantages besides the ability to control infections and kill
many bacteria: unlike the common antibiotics and deter-
gents, nanoparticles are not toxic, stable for long periods, and
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Figure 1: Original FE-SEM images showing the morphology of different nanomaterials produced at Sapienza-CNIS-DIAEE: (a) graphene
nanoplatelets (GNPs); (b-c) zinc-oxide nanowalls (ZnO-NWs); (d) zinc-oxide nanoparticles (ZnO-NPs); (e-f) zinc-oxide microrods (ZnO-
MRs); and (g-h) zinc-oxide-decorated GNPs (ZNGs).
simple to produce. Moreover, many chemical disinfectants
have positive but above all negative aspects: there is no disin-
fectant with maximum effectiveness against a wide spectrum
of pathogens; each case requires the choice of the most
appropriate disinfectant, which depends on several factors,
such as concentration, time of action, and the type of surface
andmicroorganism.Many detergents could be contaminated
by a wrong method of conservation and they could cause
6 Journal of Nanomaterials
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Figure 2: Original FE-SEM images of Staphylococcus aureus (a) wrapped by a GNP (b).
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Figure 3: Mechanical damage of cell wall produced by sharp edges in 2D (a) or 1D (b) or hybrid 1D-2D (c) nanostructures.
Graphene
sheet
Bacterium
cell
Figure 4: Inhibition of cell adhesion over a substrate induced by
graphene.
hardening of plastics and a long-term deterioration of the
treated materials. Therefore new generation nanomaterials
may allow overcoming all these limitations and allow us to
exploit only the positive aspects offered by these innovative
applications. In the last years, more elaborated antimicrobial
coatings were investigated and graphene-based nanomaterial
emerged as promising antibacterial treatment. Layers of
graphene-based nanomaterial can be employed as a novel
surface coating resin or as a new fabrication material for
medical devices and commonobjects touched by patients and
hospital staff that require good disinfection and particular
sanitation in the resistant-antibiotic era.
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